Who are Haemonetics's decision-makers?
Haemonetics's official leadership and governance pages are the safest source for named executives.
- Primary buyers
- Finance, IT, operations, security, product, or commercial leadership
- Company status
- Public company; NYSE: HAE
- HQ
- Boston, MA
- Category
- Blood and plasma management technology
- Decision style
- Public-company buying committee
- Best source
- Official leadership or IR page
- Haemonetics executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
- Haemonetics finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, and budget discipline.
- Haemonetics operations or technology leadershipOperations, product, technology, security, or commercial leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operational-improvement purchases.
Who leads Haemonetics?
Haemonetics's named leaders should be verified directly on the company's official leadership, governance, or investor-relations page. The profile intentionally avoids invented executive emails and treats official contact routes as the safe default.
Who owns buying decisions at Haemonetics?
The buying committee depends on the offer. Finance and procurement usually control commercial approval, while IT, security, product, operations, legal, field, clinical, industrial, or commercial leaders shape requirements and vendor evaluation.
How should sellers map the account?
Start with headquarters and public leadership, then map functional owners by product area. Use filings, job posts, partner announcements, security pages, engineering posts, and investor materials to identify the active initiative behind a buying cycle.
As of June 2026.Sources:Haemonetics official websiteHaemonetics investor relations or company newsBuiltWith public technology profile
Haemonetics — frequently asked questions
